| breast cancer - adjuvant | breast cancer - triple negative | ||||
| breast cancer - adjuvant | mBC - TNBC - L1 - all population | mBC-Triple negative (TNBC) - 2nd Line (L2) | mBC - TNBC - L2 - all population | es-BC - TNBC - NA - all population | |
| poly ADP-ribose polymerase (PARP) inhibitor | |||||
| olaparib | OlympiA ... | OlympiAD | OlympiA ... | ||
| talazoparib | EMBRACA | ||||
| veliparib plus paclitaxel plus carboplatin | BrighTNess ... BrighTNess ... | ||||
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
